JEREMY BROWN: Open Payments
NPI 1912212093 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,757 in 76 payments from 26 companies in 2025. Trend: 2023 $1,750 · 2024 $1,933 · 2025 $1,757
Food & beverage: $1,658Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $296 |
| PFIZER INC. | 11 | $221 |
| Novo Nordisk Inc | 8 | $143 |
| Astellas Pharma US Inc | 2 | $116 |
| Amgen Inc. | 5 | $106 |
| Seqirus USA Inc | 3 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| ABBVIE INC. | 4 | $83 |
| Aimmune Therapeutics, Inc. | 3 | $78 |
| Lilly USA, LLC | 4 | $74 |
Products named: NURTEC ODT, Wegovy, REXULTI, ZENPEP, Fluad, MOUNJARO, JARDIANCE, KRYSTEXXA.
Industry payments across CO — which companies pay providers there.
